Literature DB >> 18285425

High frequency of genomic deletions--and a duplication--in the LIS1 gene in lissencephaly: implications for molecular diagnosis.

D Mei1, R Lewis, E Parrini, L P Lazarou, C Marini, D T Pilz, R Guerrini.   

Abstract

BACKGROUND: LIS1 is the main gene causing classical (isolated) lissencephaly predominating in the posterior brain regions (p>a). However, about 40% of patients with this malformation pattern show no abnormality after fluorescence in situ hybridisation (FISH) analysis of the 17p13.3 region and LIS1 sequencing. To investigate whether alternative gene(s) or genomic deletions/duplications of LIS1 may account for the high percentage of individuals who show no abnormalities on FISH and sequencing, we performed multiplex ligation dependent probe amplification assay (MLPA) in a series of patients.
METHODS: We initially performed DNA sequencing in 45 patients with isolated lissencephaly with a p>a gradient, in whom FISH had revealed normal results. We subsequently performed MLPA in those who were mutation negative, and long range polymerase chain reaction (PCR) to characterise the breakpoint regions in patients in whom the deletions were small enough.
RESULTS: We found LIS1 mutations in 44% of patients (20/45) of the whole sample and small genomic deletions/duplications in 76% of the remaining (19/25). Deletions were much more frequent than duplications (18 vs 1). Overall, small genomic deletions/duplications represented 49% (19/39) of all LIS1 alterations and brought to 87% (39/45) the number of patients in whom any involvement of LIS1 could be demonstrated. Breakpoint characterisation, performed in 5 patients, suggests that Alu mediated recombination is a major molecular mechanism underlying LIS1 deletions.
CONCLUSIONS: LIS1 is highly specific for isolated p>a lissencephaly. The high frequency of genomic deletions/duplications of LIS1 is in keeping with the over representation of Alu elements in the 17p13.3 region. MLPA has a high diagnostic yield and should be used as first line molecular diagnosis for p>a lissencephaly.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18285425     DOI: 10.1136/jmg.2007.056507

Source DB:  PubMed          Journal:  J Med Genet        ISSN: 0022-2593            Impact factor:   6.318


  14 in total

1.  A new case of duplication of the MDS region identified by high-density SNP arrays and a review of the literature.

Authors:  Flavio Faletra; Raffaella Devescovi; Vanna Pecile; Antonella Fabretto; Marco Carrozzi; Paolo Gasparini
Journal:  J Appl Genet       Date:  2010-11-03       Impact factor: 3.240

Review 2.  Comprehensive genotype-phenotype correlation in lissencephaly.

Authors:  Ai Peng Tan; Wui Khean Chong; Kshitij Mankad
Journal:  Quant Imaging Med Surg       Date:  2018-08

3.  The Alu-rich genomic architecture of SPAST predisposes to diverse and functionally distinct disease-associated CNV alleles.

Authors:  Philip M Boone; Bo Yuan; Ian M Campbell; Jennifer C Scull; Marjorie A Withers; Brett C Baggett; Christine R Beck; Christine J Shaw; Pawel Stankiewicz; Paolo Moretti; Wendy E Goodwin; Nichole Hein; John K Fink; Moon-Woo Seong; Soo Hyun Seo; Sung Sup Park; Izabela D Karbassi; Sat Dev Batish; Andrés Ordóñez-Ugalde; Beatriz Quintáns; María-Jesús Sobrido; Susanne Stemmler; James R Lupski
Journal:  Am J Hum Genet       Date:  2014-07-24       Impact factor: 11.025

Review 4.  Genetic Basis of Brain Malformations.

Authors:  Elena Parrini; Valerio Conti; William B Dobyns; Renzo Guerrini
Journal:  Mol Syndromol       Date:  2016-08-27

5.  Intragenic deletions and duplications of the LIS1 and DCX genes: a major disease-causing mechanism in lissencephaly and subcortical band heterotopia.

Authors:  Eden V Haverfield; Amanda J Whited; Kristin S Petras; William B Dobyns; Soma Das
Journal:  Eur J Hum Genet       Date:  2008-12-03       Impact factor: 4.246

Review 6.  CNV and nervous system diseases--what's new?

Authors:  W Gu; J R Lupski
Journal:  Cytogenet Genome Res       Date:  2009-03-11       Impact factor: 1.636

Review 7.  Genetic basis in epilepsies caused by malformations of cortical development and in those with structurally normal brain.

Authors:  Danielle M Andrade
Journal:  Hum Genet       Date:  2009-06-18       Impact factor: 4.132

8.  Duplication within the SEPT9 gene associated with a founder effect in North American families with hereditary neuralgic amyotrophy.

Authors:  Megan L Landsverk; Elizabeth K Ruzzo; Heather C Mefford; Karen Buysse; Jillian G Buchan; Evan E Eichler; Elizabeth M Petty; Esther A Peterson; Dana M Knutzen; Karen Barnett; Martin R Farlow; Judy Caress; Gareth J Parry; Dianna Quan; Kathy L Gardner; Ming Hong; Zachary Simmons; Thomas D Bird; Phillip F Chance; Mark C Hannibal
Journal:  Hum Mol Genet       Date:  2009-01-12       Impact factor: 6.150

9.  Alu-mediated diverse and complex pathogenic copy-number variants within human chromosome 17 at p13.3.

Authors:  Shen Gu; Bo Yuan; Ian M Campbell; Christine R Beck; Claudia M B Carvalho; Sandesh C S Nagamani; Ayelet Erez; Ankita Patel; Carlos A Bacino; Chad A Shaw; Paweł Stankiewicz; Sau Wai Cheung; Weimin Bi; James R Lupski
Journal:  Hum Mol Genet       Date:  2015-04-23       Impact factor: 6.150

10.  An isolated case of lissencephaly caused by the insertion of a mitochondrial genome-derived DNA sequence into the 5' untranslated region of the PAFAH1B1 (LIS1) gene.

Authors:  David S Millar; Carolyn Tysoe; Lazarus P Lazarou; Daniela T Pilz; Shehla Mohammed; Katharine Anderson; Nadia Chuzhanova; David N Cooper; Rachel Butler
Journal:  Hum Genomics       Date:  2010-08       Impact factor: 4.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.